KR102135486B1 - 다능성 간세포 유래 조직의 동결 보존 방법 - Google Patents
다능성 간세포 유래 조직의 동결 보존 방법 Download PDFInfo
- Publication number
- KR102135486B1 KR102135486B1 KR1020147017031A KR20147017031A KR102135486B1 KR 102135486 B1 KR102135486 B1 KR 102135486B1 KR 1020147017031 A KR1020147017031 A KR 1020147017031A KR 20147017031 A KR20147017031 A KR 20147017031A KR 102135486 B1 KR102135486 B1 KR 102135486B1
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- cryopreservation
- cell
- pluripotent stem
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 64
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 55
- 210000001778 pluripotent stem cell Anatomy 0.000 title claims abstract description 50
- 210000004027 cell Anatomy 0.000 claims abstract description 151
- 239000002826 coolant Substances 0.000 claims abstract description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 107
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 68
- 230000002207 retinal effect Effects 0.000 claims description 68
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 229930006000 Sucrose Natural products 0.000 claims description 23
- 239000005720 sucrose Substances 0.000 claims description 23
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 19
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 230000002338 cryopreservative effect Effects 0.000 claims description 14
- 230000001681 protective effect Effects 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 5
- 229940113088 dimethylacetamide Drugs 0.000 claims description 3
- BTVWZWFKMIUSGS-UHFFFAOYSA-N dimethylethyleneglycol Natural products CC(C)(O)CO BTVWZWFKMIUSGS-UHFFFAOYSA-N 0.000 claims 3
- 230000000717 retained effect Effects 0.000 claims 1
- 229920005862 polyol Polymers 0.000 abstract description 19
- 150000003077 polyols Chemical class 0.000 abstract description 19
- 150000003462 sulfoxides Chemical class 0.000 abstract description 19
- 210000001519 tissue Anatomy 0.000 description 123
- 239000000243 solution Substances 0.000 description 55
- 239000013598 vector Substances 0.000 description 48
- 230000004069 differentiation Effects 0.000 description 31
- 210000003494 hepatocyte Anatomy 0.000 description 22
- 239000005090 green fluorescent protein Substances 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 239000002577 cryoprotective agent Substances 0.000 description 16
- 238000007710 freezing Methods 0.000 description 16
- 230000008014 freezing Effects 0.000 description 16
- 230000006698 induction Effects 0.000 description 13
- 238000001764 infiltration Methods 0.000 description 13
- 230000008595 infiltration Effects 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 230000035515 penetration Effects 0.000 description 11
- 102100029757 Retinal homeobox protein Rx Human genes 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000010367 cloning Methods 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 229920001542 oligosaccharide Polymers 0.000 description 7
- 150000002482 oligosaccharides Chemical class 0.000 description 7
- 208000003098 Ganglion Cysts Diseases 0.000 description 6
- 208000005400 Synovial Cyst Diseases 0.000 description 6
- 210000001671 embryonic stem cell Anatomy 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- -1 amide compounds Chemical class 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- 210000000411 amacrine cell Anatomy 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 210000002287 horizontal cell Anatomy 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 210000001236 prokaryotic cell Anatomy 0.000 description 4
- 239000011814 protection agent Substances 0.000 description 4
- 230000001172 regenerating effect Effects 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 238000004017 vitrification Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 239000002771 cell marker Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000003104 tissue culture media Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 101150008375 Pou4f1 gene Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 101150116803 RAX gene Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 210000004720 cerebrum Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 210000001164 retinal progenitor cell Anatomy 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 101150086009 CRIP2 gene Proteins 0.000 description 1
- 101100297345 Caenorhabditis elegans pgl-2 gene Proteins 0.000 description 1
- 101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 1
- 108010028326 Calbindin 2 Proteins 0.000 description 1
- 102100021849 Calretinin Human genes 0.000 description 1
- 101100239628 Danio rerio myca gene Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 239000006147 Glasgow's Minimal Essential Medium Substances 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101150039798 MYC gene Proteins 0.000 description 1
- 241001467578 Microbacterium Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 1
- 101150081664 PAX6 gene Proteins 0.000 description 1
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
- 102100034572 Recoverin Human genes 0.000 description 1
- 108010076570 Recoverin Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
- 102100040756 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 101150086694 SLC22A3 gene Proteins 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 102100038126 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 101100459258 Xenopus laevis myc-a gene Proteins 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 102000014823 calbindin Human genes 0.000 description 1
- 108060001061 calbindin Proteins 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008150 cryoprotective solution Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 208000002854 epidermolysis bullosa simplex superficialis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 238000011419 induction treatment Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 101150087532 mitF gene Proteins 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- PJPOCNJHYFUPCE-UHFFFAOYSA-N picen-1-ol Chemical compound C1=CC=CC2=C(C=CC=3C4=CC=C5C=CC=C(C=35)O)C4=CC=C21 PJPOCNJHYFUPCE-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 101150027852 pou3f2 gene Proteins 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011258208A JP6012164B2 (ja) | 2011-11-25 | 2011-11-25 | 多能性幹細胞由来の組織の凍結保存方法 |
| JPJP-P-2011-258208 | 2011-11-25 | ||
| PCT/JP2012/080365 WO2013077424A1 (ja) | 2011-11-25 | 2012-11-22 | 多能性幹細胞由来の組織の凍結保存方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140103979A KR20140103979A (ko) | 2014-08-27 |
| KR102135486B1 true KR102135486B1 (ko) | 2020-07-17 |
Family
ID=48469865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147017031A Active KR102135486B1 (ko) | 2011-11-25 | 2012-11-22 | 다능성 간세포 유래 조직의 동결 보존 방법 |
Country Status (11)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2880948T3 (es) * | 2014-05-12 | 2021-11-26 | Roosterbio Inc | Células listas para imprimir y dispositivos integrados |
| CN105432597B (zh) * | 2014-08-29 | 2018-08-03 | 马燕琳 | 冷冻保存诱导多能干细胞的试剂盒及方法 |
| WO2017010544A1 (ja) * | 2015-07-15 | 2017-01-19 | テルモ株式会社 | 多能性幹細胞または脂肪組織もしくは骨髄由来の間葉系幹細胞由来の心筋細胞の凍結保存方法 |
| JP2017046649A (ja) * | 2015-09-02 | 2017-03-09 | 大日本印刷株式会社 | 細胞凍結保存容器 |
| JP6860878B2 (ja) * | 2016-11-09 | 2021-04-21 | 国立大学法人 筑波大学 | 昆虫系統の凍結保存方法 |
| EP3354737B1 (en) * | 2017-01-25 | 2020-08-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Cell-free protein synthesis system |
| CN107173382B (zh) * | 2017-07-14 | 2020-12-01 | 重庆市畜牧科学院 | 猪胎儿成纤维细胞冻存液 |
| MY199544A (en) | 2017-07-20 | 2023-11-06 | Riken | Method for preserving neural tissue |
| CN108552156A (zh) * | 2017-11-13 | 2018-09-21 | 广东艾时代生物科技有限责任公司 | 一种无血清的诱导多功能干细胞冻存液及冻存方法 |
| JP7000212B2 (ja) * | 2018-03-14 | 2022-01-19 | 旭化成株式会社 | 幹細胞の凍結保存液 |
| CN110352951A (zh) * | 2018-11-15 | 2019-10-22 | 崔磊 | 一种无血清无dmso组织工程骨冻存液及其制备和冻存方法 |
| CN109666623B (zh) * | 2018-11-30 | 2022-07-26 | 中山大学中山眼科中心 | 一种三维视网膜组织的冷冻保存及复苏方法 |
| JPWO2021045122A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2019-09-02 | 2021-03-11 | ||
| IL293137A (en) * | 2019-11-20 | 2022-07-01 | Sumitomo Pharma Co Ltd | Method for freezing neural cells |
| CA3162273A1 (en) * | 2019-11-20 | 2021-05-27 | Sumitomo Pharma Co., Ltd. | Method for freezing cell aggregates |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008011070A2 (en) | 2006-07-19 | 2008-01-24 | Reprocure, Llc | A method of oocyte cryopreservation including piercing the zona pellucida prior to vitrification |
| WO2009051671A1 (en) | 2007-10-12 | 2009-04-23 | Advanced Cell Technology, Inc. | Improved methods of producing rpe cells and compositions of rpe cells |
| WO2009155430A2 (en) | 2008-06-18 | 2009-12-23 | The Cleveland Clinic Foundation | Systems and methods for vitrifying tissue |
| JP2011036196A (ja) * | 2009-08-12 | 2011-02-24 | Institute Of Physical & Chemical Research | 生物材料用ガラス化液、ガラス化キット、及びその利用 |
| WO2011028524A1 (en) | 2009-08-24 | 2011-03-10 | Wisconsin Alumni Research Foundation | Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same |
| WO2011047469A1 (en) | 2009-10-19 | 2011-04-28 | The Governors Of The University Of Alberta | Cryopreservation of articular cartilage |
| WO2011055855A1 (en) | 2009-11-05 | 2011-05-12 | Riken | A method for differentiation induction in cultured stem cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559298A (en) * | 1982-11-23 | 1985-12-17 | American National Red Cross | Cryopreservation of biological materials in a non-frozen or vitreous state |
| US5336616A (en) * | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
| US5518878A (en) * | 1993-09-15 | 1996-05-21 | Organogenesis Inc. | Cryopreservation of cultured skin or cornea equivalents with agitation |
| US6713245B2 (en) * | 1998-07-06 | 2004-03-30 | Diacrin, Inc. | Methods for storing neural cells such that they are suitable for transplantation |
| JP3694730B2 (ja) * | 2000-03-02 | 2005-09-14 | 国立大学法人京都大学 | 組織の冷却保存液 |
| US6519954B1 (en) * | 2000-06-12 | 2003-02-18 | Supachill International Pty. Ltd. | Cryogenic preservation of biologically active material using high temperature freezing |
| JP2002325571A (ja) * | 2001-04-27 | 2002-11-12 | Purotekku:Kk | 網膜の分化誘導方法 |
| US6921633B2 (en) * | 2002-11-18 | 2005-07-26 | Biolife Solutions Incorporated | Methods and compositions for the preservation of cells, tissues or organs in the vitreous state |
| US7278278B2 (en) * | 2003-06-12 | 2007-10-09 | 21St Century Medicine, Inc. | Cryogenic storage system |
| WO2005045007A1 (ja) * | 2003-11-06 | 2005-05-19 | Kyoto University | 幹細胞の凍結保存法およびシステム |
| JP4790370B2 (ja) | 2005-10-17 | 2011-10-12 | 公益財団法人実験動物中央研究所 | 実験動物初期胚のガラス化保存方法 |
| EP2314671B1 (en) | 2008-06-06 | 2022-08-03 | Riken | Method for culture of stem cell |
| US20110004304A1 (en) * | 2009-03-20 | 2011-01-06 | Tao Sarah L | Culturing retinal cells and tissues |
| KR20120126634A (ko) * | 2011-05-12 | 2012-11-21 | 김수신 | 조직 보관 방법 |
| KR101473315B1 (ko) * | 2013-09-09 | 2014-12-16 | 경북대학교병원 | 양수 줄기세포의 냉동보존을 위한 동결배지 조성물 및 양수 줄기세포의 냉동보존 방법 |
| WO2017043605A1 (ja) * | 2015-09-08 | 2017-03-16 | 大日本住友製薬株式会社 | 網膜色素上皮細胞の製造方法 |
-
2011
- 2011-11-25 JP JP2011258208A patent/JP6012164B2/ja active Active
-
2012
- 2012-11-22 EP EP12851379.3A patent/EP2784154B1/en active Active
- 2012-11-22 CN CN201280058085.8A patent/CN103958669A/zh active Pending
- 2012-11-22 AU AU2012341416A patent/AU2012341416B2/en active Active
- 2012-11-22 ES ES12851379T patent/ES2743553T3/es active Active
- 2012-11-22 KR KR1020147017031A patent/KR102135486B1/ko active Active
- 2012-11-22 CA CA2856850A patent/CA2856850C/en active Active
- 2012-11-22 IN IN4598CHN2014 patent/IN2014CN04598A/en unknown
- 2012-11-22 CN CN201710914871.8A patent/CN107736337A/zh active Pending
- 2012-11-22 US US14/360,488 patent/US11234434B2/en active Active
- 2012-11-22 WO PCT/JP2012/080365 patent/WO2013077424A1/ja active Application Filing
-
2018
- 2018-08-15 HK HK18110477.1A patent/HK1250885A1/zh unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008011070A2 (en) | 2006-07-19 | 2008-01-24 | Reprocure, Llc | A method of oocyte cryopreservation including piercing the zona pellucida prior to vitrification |
| WO2009051671A1 (en) | 2007-10-12 | 2009-04-23 | Advanced Cell Technology, Inc. | Improved methods of producing rpe cells and compositions of rpe cells |
| WO2009155430A2 (en) | 2008-06-18 | 2009-12-23 | The Cleveland Clinic Foundation | Systems and methods for vitrifying tissue |
| JP2011036196A (ja) * | 2009-08-12 | 2011-02-24 | Institute Of Physical & Chemical Research | 生物材料用ガラス化液、ガラス化キット、及びその利用 |
| WO2011028524A1 (en) | 2009-08-24 | 2011-03-10 | Wisconsin Alumni Research Foundation | Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same |
| WO2011047469A1 (en) | 2009-10-19 | 2011-04-28 | The Governors Of The University Of Alberta | Cryopreservation of articular cartilage |
| WO2011055855A1 (en) | 2009-11-05 | 2011-05-12 | Riken | A method for differentiation induction in cultured stem cells |
Non-Patent Citations (1)
| Title |
|---|
| Kasai. et al., Reproductive BioMedicine Online, 2004, Vol.9, no.2, p.164-170 (2004. 6. 11.)* |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013110988A (ja) | 2013-06-10 |
| US11234434B2 (en) | 2022-02-01 |
| IN2014CN04598A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-09-18 |
| WO2013077424A1 (ja) | 2013-05-30 |
| HK1250885A1 (zh) | 2019-01-18 |
| JP6012164B2 (ja) | 2016-10-25 |
| AU2012341416B2 (en) | 2018-07-05 |
| EP2784154A4 (en) | 2015-05-27 |
| ES2743553T3 (es) | 2020-02-19 |
| AU2012341416A1 (en) | 2014-06-26 |
| CA2856850C (en) | 2020-06-30 |
| US20140342346A1 (en) | 2014-11-20 |
| EP2784154B1 (en) | 2019-06-05 |
| CA2856850A1 (en) | 2013-05-30 |
| CN107736337A (zh) | 2018-02-27 |
| EP2784154A1 (en) | 2014-10-01 |
| KR20140103979A (ko) | 2014-08-27 |
| CN103958669A (zh) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102135486B1 (ko) | 다능성 간세포 유래 조직의 동결 보존 방법 | |
| US20210228645A1 (en) | Methods for producing retinal tissue and retina-related cell | |
| Jang et al. | Cryopreservation and its clinical applications | |
| US20250269086A1 (en) | Cell Population for Transplantation and Method for Producing Same | |
| Quinn et al. | Production of iPS-derived human retinal organoids for use in transgene expression assays | |
| CA3162268A1 (en) | Method for freezing neural cells | |
| JP2013128476A (ja) | 眼杯様構造体の製造方法 | |
| Honaramooz | Cryopreservation of testicular tissue | |
| JP6067232B2 (ja) | 網膜層特異的神経細胞を製造する方法 | |
| JP2013128475A (ja) | 網膜組織の製造方法 | |
| WO2023122672A1 (en) | Cryopreservation compositions and methods using red blood cells | |
| Mojica-Perez et al. | Cryopreservation of Human Cortical Organoids Using Vitrification | |
| Inoshita et al. | Monitoring mitochondrial changes by alteration of the PINK1-parkin signaling in Drosophila | |
| Vasir et al. | Normalization of hyperglycemia in diabetic rats by intraportal transplantation of cryopreserved islets from four donors | |
| Pimentel | Cryoprotection and cytotoxicity resistance of tardigrade stress resistant genes in U87 cells for improved cryopreservation | |
| JP2010094076A (ja) | 哺乳動物の組織の凍結保存方法、非ヒト哺乳動物の核移植胚及びクローン非ヒト哺乳動物 | |
| Al-Hasani et al. | Future Aspects in Human Cryopreservation | |
| Reardon et al. | 142. Two-step freezing of HUVEC in the absence of cryoprotectant | |
| Talwar et al. | Clinical Applications of Vitrification | |
| Vajta et al. | -Oocyte Storage in Domestic Species | |
| HK40013603A (en) | Cell population for transplantation and method for producing same | |
| Malpique et al. | 20. Improved cryopreservation protocols for brain cell aggregates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20140620 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20171109 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20181120 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190926 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200414 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200713 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20200713 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20230619 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240620 Start annual number: 5 End annual number: 5 |